Check out your Company Bowl for anonymous work chats.
Amplity Commercial Solutions designs and implements tailored, effective customer engagement teams. Depending on your specific brand objectives, we’ll partner with you to formulate the appropriate amount and type of engagement to meet the goals of your brand’s strategy.
Engagement with key experts and healthcare professionals is critical to growing your brand. Amplity’s Medical Communications team leverages our strong industry relationships to provide you with access to these audiences. Additionally, we work with you to customize a data-driven communications strategy to effectively reach your key customers directly, through scientific publications, industry/disease-specific associations, and events. like 11
TODAY: Meet Amplity at the San Antonio Breast Cancer Symposium! We attend events like #SABCS23 as part of our dedication to helping our oncology clients meet the needs of breast cancer patients through high-quality and equal access to care.
TODAY: Amplity's Market Access team is attending the AMSUS Sustaining Members conference in Crystal City, VA. As industry leaders in federal access strategy, we're attending AMSUS to meet with life science companies seeking an experienced partner to help them navigate the VA, DoD, and federal contracting. Meet with Bruce Valentine and Nikolina Janakievski to find out how Amplity Market Access consulting can improve your business in the VA and DoD.
In an ongoing effort to provide nutritional guidance and wellness support to people affected by cancer, Amplity and Viver Health LLC Health LLC have partnered to develop a Nutrition and Wellness in Cancer Care special issue for patients and caregivers. The issue will be distributed via Amplity's journals in Q1 of 2024. If interested in supporting this initiative, please contact Victoria Barghout (vbarghout@viverhealth.com) and Stephen Solano (stephen.solano@amplity.com).
We often hear from companies a year into launch saying they wish they had deployed an FRM team immediately at launch. They recognize that they left business on the table. More importantly, patients who needed and deserved the product during that year did not get it. Read our article for the three considerations pharma must consider when deploying FRMs at launch: https://lnkd.in/gDfTskWJ
In an ongoing effort to provide nutritional guidance and wellness support to people affected by cancer, Amplity and Viver Health LLC Health LLC have partnered to develop a Nutrition and Wellness in Cancer Care special issue for patients and caregivers. The issue will be distributed via Amplity's journals in Q1 of 2024. If interested in supporting this initiative, please contact Victoria Barghout (vbarghout@viverhealth.com) and Stephen Solano (stephen.solano@amplity.com).
The industry is witnessing a pivotal moment with the loss of exclusivity for adalimumab, marking the largest event of its kind. Several adalimumab biosimilars have entered the market, and more are expected to follow. As competition intensifies, PBMs and manufacturers must strategically position themselves in the market. Amplity's Nikolina Janakievski, Associate Director and Lead Strategist, Market Access, co-published this article for Life Science Leader to delve into the strategies necessary to navigate this evolving landscape, demonstrating how Amplity's market access team is equipped to provide the creative strategy and predictive analytics necessary to execute a successful biosimilar launch. Visit https://lnkd.in/ebq6PcnS to read a copy of the Life Science Leader article.
As part of the movement to help pharma more efficiently achieve clinical trial goals and meet research timelines, Amplity is disrupting the traditional pharma/CRO dynamic with the addition of Clinical Trial Liaisons (CTLs), a role designed to complement the important work of Clinical Research Associates (CRAs). Read more: https://lnkd.in/eAiUFHTf
The industry is witnessing a pivotal moment with the loss of exclusivity for adalimumab, marking the largest event of its kind. Several adalimumab biosimilars have entered the market, and more are expected to follow. As competition intensifies, PBMs and manufacturers must strategically position themselves in the market. Amplity's Nikolina Janakievski, Associate Director and Lead Strategist, Market Access, co-published this article for Life Science Leader to delve into the strategies necessary to navigate this evolving landscape, demonstrating how Amplity's market access team is equipped to provide the creative strategy and predictive analytics necessary to execute a successful biosimilar launch. Visit https://lnkd.in/ebq6PcnS to read a copy of the Life
